Issue

Vol. 35 No. 9 (2023): Vol 35 Issue 9, 2023

Copyright (c) 2023 J. Panchal and J. Dhalani

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Novel Ultra-Fast Liquid Chromatography Method for Simultaneous Quantification of Metformin Hydrochloride and Remogliflozin Etabonate

https://doi.org/10.14233/ajchem.2023.27910
J PANCHAL
Department of Chemistry, School of Science, R K University, Rajkot-360020, India
https://orcid.org/0000-0002-5344-7020
J. Dhalani
Department of Chemistry, School of Science, R K University, Rajkot-360020, India
https://orcid.org/0000-0002-2594-1590

Corresponding Author(s) : J. Dhalani

jayesh.dhalani@rku.ac.in

Asian Journal of Chemistry, Vol. 35 No. 9 (2023): Vol 35 Issue 9, 2023

Abstract

An advanced formulation having remogliflozin etabonate (REM) and metformin hydrochloride (MET) for the treatment of diabetes was recently approved. However, there hasn't been any information reported on a UFLC technique for simultaneously quantifying both active substances. Therefore, aim of the study was the development of an ultra-fast isocratic liquid chromatography method for quantification of MET and REM in API and dosage form. The reversed phase-UFLC method was developed with a very short run time of only 3 min with no interference due to blank. The compounds were separated using Shimadzu Sim-pack XR ODS (75 mm × 3 mm, 2.2 μ) column with mobile phase consisting of buffer (0.1% phosphoric acid):acetonitrile (30:70). The developed method was validated as per ICH-Q2(R1). The linearity was established in the range of 0.01-125 ppm and 0.01-25 ppm for MET and REM, respectively. The average assay was found 99.4% for MET and 99.1% for REM. The accuracy was observed 98.29-99.49% for MET and 98.39-99.73% for REM. The  proposed method is very fast and simple however precise and accurate. This method is very useful for regular quality control  laboratory to quantify MET and REM in API and dosages forms. 

Keywords

UFLC Chromatography Remogliflozin etabonate Metformin
PANCHAL, J., & Dhalani, J. (2023). Novel Ultra-Fast Liquid Chromatography Method for Simultaneous Quantification of Metformin Hydrochloride and Remogliflozin Etabonate. Asian Journal of Chemistry, 35(9), 2055–2060. https://doi.org/10.14233/ajchem.2023.27910
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. Z.-H. Wu, Y. Tang and Q. Cheng, Acta Diabetol., 58, 139 (2021); https://doi.org/10.1007/s00592-020-01546-0
  2. P. Saeedi, I. Petersohn, P. Salpea, B. Malanda, S. Karuranga, N. Unwin, S. Colagiuri, L. Guariguata, A.A. Motala, K. Ogurtsova, J.E. Shaw, D. Bright and R. Williams, Diabetes Res. Clin. Pract., 157, 107843 (2019); https://doi.org/10.1016/j.diabres.2019.107843
  3. C. Mathers and D. Loncar, PLoS Med., 3, 442 (2006); https://doi.org/10.1371/journal.pmed.0030442
  4. D. Kawanami, Y. Takashi, H. Takahashi, R. Motonaga and M. Tanabe, Antioxidants, 10, 246 (2021); https://doi.org/10.3390/antiox10020246
  5. D. Drucker and M. Nauck, Lancet, 368, 1696 (2006); https://doi.org/10.1016/S0140-6736(06)69705-5
  6. I. Huang, M. Lim and R. Pranata, Diabetes Metab. Syndr., 14, 395 (2020); https://doi.org/10.1016/j.dsx.2020.04.018
  7. C.P. Elias, D.E. Antunes, M.S. Coelho, C.L. de Lima, N. Rassi, A.P.M. de Melo and A.A. Amato, Diab. Met. Synd., 11, 1 (2019); https://doi.org/10.1186/s13098-018-0396-4
  8. A. Markham, Drugs, 79, 1157 (2019); https://doi.org/10.1007/s40265-019-01150-9
  9. V. Mohan, A. Mithal, S. Joshi, S. Aravind and S. Chowdhury, Drug Des. Devel. Ther., 14, 2487 (2020); https://doi.org/10.2147/DDDT.S221093
  10. R. Dobbins, R. O’ConnorSemmes, A. Kapur, C. Kapitza, G. Golor, W. Tao, I. Mikoshiba and E. Hussey, Diabetes Obes. Metab., 14, 15 (2012); https://doi.org/10.1111/j.1463-1326.2011.01462.x
  11. National Center for Biotechnology Information, PubChem Compound Summary for CID 9871420, Remogliflozin Etabonate; Retrieved on January 25 (2021).
  12. National Center for Biotechnology Information, PubChem Compound Summary for CID 4091, Metformin; Retrieved on March 9 (2023).
  13. S. Ahsan, Endocr. Pract., 27, S62 (2021); https://doi.org/10.1016/j.eprac.2021.04.600
  14. D. Shah, I. Gondalia, V. Patel, A. Mahajan and U. Chhalotiya, J. Chem. Metrol., 14, 125 (2020); https://doi.org/10.25135/jcm.46.20.07.1734
  15. N. Itigimatha, K. Chadchan, B. Yallur and M. Hadagali, Turk. J. Pharm. Sci., 19, 213 (2022); https://doi.org/10.4274/tjps.galenos.2021.55381
  16. H. Fathima, N. T. Havannavar and A. Jahan, Asian J. Res. Chem, 15, 166 (2022); https://doi.org/10.52711/0974-4150.2022.00028
  17. M. Attimarad, K. Venugopala, B. Al-Dhubiab, R. Elgorashe and S. Shafi, Molecules, 26, 6160 (2021); https://doi.org/10.3390/molecules26206160
  18. V. Dave and P. Patel, Res. J. Pharm. Technol., 14, 2402 (2021); https://doi.org/10.52711/0974-360X.2021.00362
  19. P. Sai, B. Venkateswarlu, M. Kumudhavalli and V. Muruganantham, J. Med. Pharm. Ap. Sci., 10, 3718 (2021); https://doi.org/10.22270/jmpas.V10I5.1655
  20. P. Prajapati, H. Ahir, B. Prajapati and S. Shah, J. AOAC Int., 106, 239 (2022); https://doi.org/10.1093/jaoacint/qsac084
  21. S. Ali, P. Bharath, S. Sharif and D. Ramachandran, Curr. Trends Biotechnol. Pharm., 15, 401 (2021); https://doi.org/10.5530/ctbp.2021.4.41
  22. M. Attimarad, K. Venugopala, M. Islam, S. Shafi and A. Altaysan, Indian J. Pharm. Educ. Res., 56, 564 (2022); https://doi.org/10.5530/ijper.56.2.79
  23. J. Panchal, B. Dhaduk and J. Dhalani, Rasayan J. Chem., 16, 579 (2023); https://doi.org/10.31788/RJC.2023.1628212
  24. M. Attimarad, K. Venugopala, A. Nair, N. Sreeharsha and P. Deb, Separations, 9, 23 (2022); https://doi.org/10.3390/separations9020023
  25. M. Attimarad, A. Nair, N. Sreeharsha, B. Al-Dhubiab, K. Venugopala and P. Shinu, Indian J. Pharm. Educ. Res., 55(Suppl.1), S293 (2021); https://doi.org/10.5530/ijper.55.1s.62
  26. M. Attimarad, A. Nair, N. Sreeharsha, B. Al-Dhubiab, K. Venugopala and P. Shinu, Int. J. Environ. Res. Public Health, 18, 448 (2021); https://doi.org/10.3390/ijerph18020448
  27. M. Attimarad, R.E.E. Elgorashe, R. Subramaniam, M.M. Islam, K.N. Venugopala, S. Nagaraja and A.A. Balgoname, Separations, 7, 59 (2020); https://doi.org/10.3390/separations7040059
  28. A.S. Patil, A.B. Mundada, R.S. Shravane, P.A. Mundada and S.J. Surana, JPC-J. Planar Chromatogr., 36, 89 (2023); https://link.springer.com/article/10.1007/s00764-023-00229-0
  29. M. Attimarad, A. Nair, N. Sreeharsha, B. Al-Dhubiab, K. Venugopala and P. Shinu, Int. J. Environ. Res. Public Health, 18, 448 (2021); https://doi.org/10.3390/ijerph18020448
  30. M. Tammisetty, B. Challa and S. Puttagunta, Turk. J. Pharm. Sci., 18, 296 (2021); https://doi.org/10.4274/tjps.galenos.2020.39699
  31. R. Singh, B. Dhaduk and J. Dhalani, Results Chem., 5, 100779 (2023); https://doi.org/10.1016/j.rechem.2023.100779
  32. ICH Q2 (R1), Validation of Analytical Procedures: Text and Methodology, International Conference on Harmonization, Geneva (2005).
Read More
Author biographies is not available.
Statistic
Read Counter : 0 Download : 1